Dale S Bond1, Dawn C Buse2, Richard B Lipton2, J Graham Thomas1, Lucille Rathier3, Julie Roth4, Jelena M Pavlovic2, E Whitney Evans1, Rena R Wing1. 1. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University/The Miriam Hospital Weight Control and Diabetes Research Center, Providence, RI, USA. 2. Department of Neurology and the Montefiore Headache Center, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, USA. 3. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University/The Miriam Hospital, Providence, RI, USA. 4. Department of Neurology, Alpert Medical School of Brown University, Providence, RI, USA.
Abstract
OBJECTIVE/ BACKGROUND: Obesity is related to migraine. Maladaptive pain coping strategies (eg, pain catastrophizing) may provide insight into this relationship. In women with migraine and obesity, we cross-sectionally assessed: (1) prevalence of clinical catastrophizing; (2) characteristics of those with and without clinical catastrophizing; and (3) associations of catastrophizing with headache features. METHODS: Obese women migraineurs seeking weight loss treatment (n = 105) recorded daily migraine activity for 1 month via smartphone and completed the Pain Catastrophizing Scale (PCS). Clinical catastrophizing was defined as total PCS score ≥30. The six-item Headache Impact Test (HIT-6), 12-item Allodynia Symptom Checklist (ASC-12), Headache Management Self-Efficacy Scale (HMSE), and assessments for depression (Centers for Epidemiologic Studies Depression Scale) and anxiety (seven-item Generalized Anxiety Disorder Scale) were also administered. Using PCS scores and body mass index (BMI) as predictors in linear regression, we modeled a series of headache features (ie, headache days, HIT-6, etc) as outcomes. RESULTS: One quarter (25.7%; 95% confidence interval [CI] = 17.2-34.1%) of participants met criteria for clinical catastrophizing: they had higher BMI (37.9 ± 7.5 vs 34.4 ± 5.7 kg/m(2) , P = .035); longer migraine attack duration (160.8 ± 145.0 vs 97.5 ± 75.2 hours/month, P = .038); higher HIT-6 scores (68.7 ± 4.6 vs 64.5 ± 3.9, P < .001); more allodynia (7.0 ± 4.1 vs 4.5 ± 3.5, P < .003), depression (25.4 ± 12.4 vs 13.3 ± 9.2, P < .001), and anxiety (11.0 ± 5.2 vs 5.6 ± 4.1, P < .001); and lower self-efficacy (80.1 ± 25.6 vs 104.7 ± 18.9, P < .001) compared with participants without clinical catastrophizing. The odds of chronic migraine were nearly fourfold greater in those with (n = 8/29.6%) vs without (n = 8/10.3%) clinical catastrophizing (odds ratio = 3.68; 95%CI = 1.22-11.10, P = .021). In all participants, higher PCS scores were related to more migraine days (β = 0.331, P = .001), longer attack duration (β = 0.390, P < .001), higher HIT-6 scores (β = 0.425, P < .001), and lower HMSE scores (β = -0.437, P < .001). Higher BMI, but not higher PCS scores, was related to more frequent attacks (β = -0.203, P = .044). CONCLUSIONS: One quarter of participants with migraine and obesity reported clinical catastrophizing. These individuals had more frequent attacks/chronicity, longer attack duration, higher pain sensitivity, greater headache impact, and lower headache management self-efficacy. In all participants, PCS scores were related to several migraine characteristics, above and beyond the effects of obesity. Prospective studies are needed to determine sequence and mechanisms of relationships between catastrophizing, obesity, and migraine.
OBJECTIVE/ BACKGROUND:Obesity is related to migraine. Maladaptive pain coping strategies (eg, pain catastrophizing) may provide insight into this relationship. In women with migraine and obesity, we cross-sectionally assessed: (1) prevalence of clinical catastrophizing; (2) characteristics of those with and without clinical catastrophizing; and (3) associations of catastrophizing with headache features. METHODS:Obesewomenmigraineurs seeking weight loss treatment (n = 105) recorded daily migraine activity for 1 month via smartphone and completed the Pain Catastrophizing Scale (PCS). Clinical catastrophizing was defined as total PCS score ≥30. The six-item Headache Impact Test (HIT-6), 12-item Allodynia Symptom Checklist (ASC-12), Headache Management Self-Efficacy Scale (HMSE), and assessments for depression (Centers for Epidemiologic Studies Depression Scale) and anxiety (seven-item Generalized Anxiety Disorder Scale) were also administered. Using PCS scores and body mass index (BMI) as predictors in linear regression, we modeled a series of headache features (ie, headache days, HIT-6, etc) as outcomes. RESULTS: One quarter (25.7%; 95% confidence interval [CI] = 17.2-34.1%) of participants met criteria for clinical catastrophizing: they had higher BMI (37.9 ± 7.5 vs 34.4 ± 5.7 kg/m(2) , P = .035); longer migraine attack duration (160.8 ± 145.0 vs 97.5 ± 75.2 hours/month, P = .038); higher HIT-6 scores (68.7 ± 4.6 vs 64.5 ± 3.9, P < .001); more allodynia (7.0 ± 4.1 vs 4.5 ± 3.5, P < .003), depression (25.4 ± 12.4 vs 13.3 ± 9.2, P < .001), and anxiety (11.0 ± 5.2 vs 5.6 ± 4.1, P < .001); and lower self-efficacy (80.1 ± 25.6 vs 104.7 ± 18.9, P < .001) compared with participants without clinical catastrophizing. The odds of chronic migraine were nearly fourfold greater in those with (n = 8/29.6%) vs without (n = 8/10.3%) clinical catastrophizing (odds ratio = 3.68; 95%CI = 1.22-11.10, P = .021). In all participants, higher PCS scores were related to more migraine days (β = 0.331, P = .001), longer attack duration (β = 0.390, P < .001), higher HIT-6 scores (β = 0.425, P < .001), and lower HMSE scores (β = -0.437, P < .001). Higher BMI, but not higher PCS scores, was related to more frequent attacks (β = -0.203, P = .044). CONCLUSIONS: One quarter of participants with migraine and obesity reported clinical catastrophizing. These individuals had more frequent attacks/chronicity, longer attack duration, higher pain sensitivity, greater headache impact, and lower headache management self-efficacy. In all participants, PCS scores were related to several migraine characteristics, above and beyond the effects of obesity. Prospective studies are needed to determine sequence and mechanisms of relationships between catastrophizing, obesity, and migraine.
Authors: B Lee Peterlin; Andrea L Rosso; Michelle A Williams; Jason R Rosenberg; Jennifer A Haythornthwaite; Kathleen R Merikangas; Rebecca F Gottesman; Dale S Bond; Jian-Ping He; Alan B Zonderman Journal: Neurology Date: 2013-09-11 Impact factor: 9.910
Authors: Dale S Bond; Kevin C O'Leary; J Graham Thomas; Richard B Lipton; George D Papandonatos; Julie Roth; Lucille Rathier; Richard Daniello; Rena R Wing Journal: Contemp Clin Trials Date: 2013-03-22 Impact factor: 2.226
Authors: A Fava; D Pirritano; D Consoli; M Plastino; F Casalinuovo; S Cristofaro; C Colica; C Ermio; M De Bartolo; C Opipari; R Lanzo; A Consoli; D Bosco Journal: Eur J Neurol Date: 2013-11-15 Impact factor: 6.089
Authors: Mark A Louter; Johanneke E Bosker; Willebrordus P J van Oosterhout; Erik W van Zwet; Frans G Zitman; Michel D Ferrari; Gisela M Terwindt Journal: Brain Date: 2013-09-29 Impact factor: 13.501
Authors: Elizabeth K Seng; Dawn C Buse; Jaclyn E Klepper; Sarah J Mayson; Amy S Grinberg; Brian M Grosberg; Jelena M Pavlovic; Matthew S Robbins; Sarah E Vollbracht; Richard B Lipton Journal: Headache Date: 2017-01-31 Impact factor: 5.887
Authors: Samantha G Farris; J Graham Thomas; Ana M Abrantes; Richard B Lipton; Jelena Pavlovic; Todd A Smitherman; Megan B Irby; Donald B Penzien; Julie Roth; Kevin C O'Leary; Dale S Bond Journal: Cephalalgia Date: 2017-12-13 Impact factor: 6.292
Authors: Arão Belitardo de Oliveira; Juliane Prieto Peres Mercante; Isabela M Benseñor; Alessandra C Goulart; Mario Fernando Prieto Peres Journal: Neurol Sci Date: 2021-09-24 Impact factor: 3.307
Authors: Rachel Galioto; Kevin C O'Leary; J Graham Thomas; Kathryn Demos; Richard B Lipton; John Gunstad; Jelena M Pavlović; Julie Roth; Lucille Rathier; Dale S Bond Journal: J Headache Pain Date: 2017-03-29 Impact factor: 7.277